Clinical Trial Update: Safety of Indacaterol in Patients (≥ 12 Years) With Moderate to Severe Persistent Asthma [Phase 3]

View source ↗

Summary

This Phase 3 trial update reports safety data for indacaterol in patients aged 12 and older with moderate to severe persistent asthma, with results published in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Indacaterol (indacaterol)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Asthma | Phase 3 | Status: COMPLETED | Results posted: 2011-08-19